Skip to main content

MoneyWorks4Me

Clarification sought from Aurobindo Pharma

01 Feb 2016 Evaluate

The Exchange has sought clarification from Aurobindo Pharma today with reference to news displayed - in MONEYCONTROL on February 01, 2016 : ‘unit 3 and unit 7 inspected USFDA,UNIT 7 sees few observations’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1794.30
Dr. Reddys Labs. 1353.10
Cipla 1369.05
Lupin 1988.00
Zydus Lifesciences 1201.20
View more..